The National Institute for Health and Care Excellence has recommended the novel anti-cholesterol drug inclisiran (Leqvio), described as a “potential game-changer” in cardiovascular prevention. NICE said the drug should be an option for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a…
The post NICE approves ‘ground-breaking’ new cholesterol-lowering drug appeared first on Nursing Times.
0 comments:
Post a Comment